Tetra Bio Pharma Inc (OTCMKTS:TBPMF) today gave an update revealing its latest move with Alternavida S.A. de C.V.The two business giants got into definitive co-development and commercialization deal in line with a product known as CAUMZTM (PPP011). They will focus on the sale development, marketing, and distribution activities of this leading product.
The CEO of Tetra Bio-Pharma, who is also its Chief Regulatory Officer, Dr. Guy Chamberland, has spoken in relation to the latest development. According to the leader, the opioid crisis is spreading at an astounding rate, and something needs to be done about the matter. It started from North America, and now it is finding its way into Mexico and other states.
Reports have placed the opioid epidemic at the top of the list when it comes to those conditions that require immediate attention. Scientists have termed the epidemic one of the biggest challenges the world is facing currently.
Chamberland is quite pleased with Alternavida and its dedication to opening up clinical sites to conduct trials for CAUMZTM.
Alternavida’s dedication to progress
Alternavida has been making strong efforts targeted at pushing for the approval of the drug. The aim has been to see the drug help the various suffering persons from around the globe.
The official adds that the business should be recognized for its lead role in the health and wellness sector.
Tetra Bio-Pharma has been quite vigilant, and so far, it has conducted discussions with several potential partners. However, it spotted Alternavida’s undying interest to work with it towards the development of CAUMZTM and marketing it.
Focus into the future
The business leader is optimistic that its relationship with the partner will be a meaningful one. It looks forward to co-operating with it as they seek to expand their reach within Mexico.
The terms of the deal are quite clear, with Alternavida expected to finance two trials in Mexico. Asides from that, it will undertake the registration exercise of the product in Mexico and see to its commercialization.
Tetra is looking forward to ramping up its efforts in the operation of its clinical sites in the US, Canada, and Mexico. It also seeks to expand its business to more territories.
Planet 13 Holdings Inc. (OTCMKTS:PLNHF) Signs Purchase Agreement To Acquire 45,000 Sq. ft. Facility In Nevada
Post Views: 107 Planet 13 Holdings Inc. (OTCMKTS:PLNHF) announced the signing of an asset purchase agreement subject to which it...
Indus Holdings Inc. (OTCMKTS:INDXF) Terminates Its Pending $20 million Acquisition Agreement Of W Vapes Assets
Post Views: 145 Indus Holdings Inc. (OTCMKTS:INDXF) announced termination of its impending acquisition of W Vapes assets that was announced...
1933 Industries Inc. (OTCMKTS:TGIFF) Introduces Pre-roll Joints And Smokable Cannabis Flower In Nevada
Post Views: 133 1933 Industries Inc. (OTCMKTS:TGIFF) announced addition of pre-joint rolls and high-quality smokable flowers to its growing consumer...
Cannabis Pharmaceuticals Inc. (OTCMKTS:CNBX) Initiates Expansion Of Its Cannabinoid Diagnostic Platform Tests In Europe
Post Views: 61 Cannabis Pharmaceuticals Inc. (OTCMKTS:CNBX) commenced expansion in the European markets to offer cancer patients tailored cannabinoid treatment...
Generex Biotechnology Corporation (OTCMKTS:GNBT) Submits Pre-IND For Ii-Key-SARS-CoV-2 Vaccine To The FDA
Post Views: 198 Generex Biotechnology Corporation (OTCMKTS:GNBT) submitted a Pre-IND update to the FDA outlining its proposed Phase I/II clinical...
cbdMD Inc. (NYSEAMERICAN:YCBD) Protecting Its CBD Technologies Through Patents and expands Partnership With Bellator MMA
Post Views: 310 cbdMD Inc. (NYSEAMERICAN:YCBD) announced an extension of the exclusive Official CBD marketing partnership with ViacomCBS’s wholly-owned subsidiary...